Dietary strawberry powder reduces blood glucose concentrations in obese and lean C57BL/6 mice, and selectively lowers plasma C-reactive protein in lean mice

British Journal of Nutrition

Volumn 108, Issue 10, 2012, Pages 1789-1799

  Parelman, Mardi A ^a   Storms, David H ^b   Kirschke, Catherine P ^b   Huang, Liping ^b   Zunino, Susan J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Blood glucose; Diet induced obesity; Inflammation; Strawberry powder

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; FREEZE DRYING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; IMMUNE RESPONSE; LEAN BODY WEIGHT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; SPLEEN CELL; STRAWBERRY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIET; DIETARY SUPPLEMENTS; FOOD ANALYSIS; FRAGARIA; FREEZE DRYING; MALE; MICE; MICE, INBRED C57BL; OBESITY; RANDOM ALLOCATION; SPLEEN;

FRAGARIA X ANANASSA; MUS;

EID: 84870011218     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512000037     Document Type: Article

References (84)

1. Pradhan AD, Cook NR, Buring JE, et al. (2003) C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thomb Vasc Biol 23, 650-655.
2. Temelkova-Kurktschiev T, Siegert G, Bergmann S, et al. (2002) Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 51, 743-749.
3. Festa A, D'Agostino R Jr, Tracy RP, et al. (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137.
4. Watson RT, Kanzaki M & Pessin JE (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 25, 177-204.
5. Tanti J-F & Jager J (2009) Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9, 753-762.
6. Hadi HA & Suwaidi JA (2007) Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 3, 853-876.
7. Ouchi N, Kihara S, Arita Y, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
8. Ferri C, Desideri G, Valenti M, et al. (1999) Early upregulation of endothelial adhesionmoleculesinobese hypertensivemen. Hypertension 34, 568-573.
9. Leinonen E, Hurt-Camejo E, Wiklund O, et al. (2003) Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166, 387-394.
10. Meigs JB, Hu FB, Rifai N, et al. (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978-1986.
11. Brake DK, Smith EO, Mersmann H, et al. (2006) ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 291, C1232-C1239.
12. Memoli B, Procino A, Calabro P, et al. (2007) Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am J Physiol Endocrinol Metab 293, E1030-E1035.
13. Ouchi N, Kihara S, Funahashi T, et al. (2003) Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107, 671-674.
14. Anty R, Bekri S, Luciani N, et al. (2006) The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 101, 1824-1833.
15. Park HS, Park JY & Yu R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69, 29-35.
16. Pradhan AD, Manson JE, Rifai N, et al. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
17. Dehghan A, van Hoek M, Sijbrands EJ, et al. (2007) Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 30, 2695-2699.
18. Gonzalez AS, Guerrero DB, Soto MB, et al. (2006) Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 60, 802-809.
19. Chen K, Li F, Li J, et al. (2006) Induction of leptin resistance though direct interaction of C-reactive protein with leptin. Nat Med 12, 425-432.
20. Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. (2006) Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann N Y Acad Sci 1083, 185-195.
21. Maeda K, Okubo K, Shimomura I, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221, 286-289.
22. Scherer PE, Williams S, Fogliano M, et al. (1995) A novel serum protein similar to C1q, produced exclusively in adipo-cytes. J Biol Chem 270, 26746-26749.
23. Devaraj S, Torok N, Dasu MR, et al. (2008) Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thomb Vasc Biol 28, 1368-1374.
24. Mito N, Hosoda T, Kato C, et al. (2000) Change of cytokine balance in diet-induced obese mice. Metabolism 49, 1295-1300.
25. Hu E, Liang P & Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271, 10697-10703.
26. Hotta K, Funahashi T, Arita Y, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thomb Vasc Biol 20, 1595-1599.
27. Weyer C, Funahashi T, Tanaka S, et al. (2001) Hypoadipo-nectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
28. Vozarova B, Weyer C, Hanson K, et al. (2001) Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9, 414-417.
29. Park HT, Cho SH, Cho GJ, et al. (2009) Relationship between serum adipocytokine levels and metabolic syndrome in menopausal women. Gynecol Endocrinol 25, 27-31.
30. De Taeye BM, Novitskaya T, Gleaves L, et al. (2006) Bone marrow plasminogen activator inhibitor-1 influences the development of obesity. J Biol Chem 281, 32796-32805.
31. Hoffler U, Hobbie K, Wilson R, et al. (2009) Diet-induced obesity is associated with hyperleptinemia, hyperinsuline-mia, hepatic steatosis, and glomerulopathy in C57Bl/6J mice. Endocrine 36, 311-325.
32. Lijnen H, Maquoi E, Demeulemeester D, et al. (2002) Modulation of fibrinolytic and gelatinolytic activity during adipose tissue development in a mouse model of nutritionally induced obesity. Thomb Haemost 88, 345-353.
33. Steppan CM, Bailey ST, Bhat S, et al. (2001) The hormone resistin links obesity to diabetes. Nature 409, 307-312.
34. Steppan CM, Brown EJ, Wright CM, et al. (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98, 502-506.
35. Lin S, Thomas TC, Storlien LH, et al. (2000) Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 24, 639-646.
36. Harte RA, Kirk EA, Rosenfeld ME, et al. (1999) Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm Metab Res 31, 570-575.
37. Weisberg SP, McCann D, Desai M, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
38. Calabro P, Chang DW, Willerson JT, et al. (2005) Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 46, 1112-1113.
39. Gao Z, Hwang D, Bataille F, et al. (2002) Serine phosphoryl-ation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277, 48115-48121.
40. Li X, Kimura H, Hirota K, et al. (2005) Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney Int 68, 569-583.
41. Kishida M, Urakaze M, Takata M, et al. (2005) PGE1 inhibits the expression of PAI-1 mRNA induced by TNF-alpha in human mesangial cells. Exp Clin Endocrinol Diabetes 113, 365-371.
42. Gallou-Kabani C, Vige A, Gross MS, et al. (2007) C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 15, 1996-2005.
43. Smith AG, Sheridan PA, Harp JB, et al. (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137, 1236-1243.
44. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, et al. (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104, 20466-20471.
45. Steppan CM, Wang J, Whiteman EL, et al. (2005) Activation of SOCS-3 by resistin. Mol Cell Biol 25, 1569-1575.
46. Yang RZ, Huang Q, Xu A, et al. (2003) Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 310, 927-935.
47. Savage DB, Sewter CP, Klenk ES, et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome prolifera-tor-activated receptor-gamma action in humans. Diabetes 50, 2199-2202.
48. Patel L, Buckels AC, Kinghorn IJ, et al. (2003) Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300, 472-476.
49. Jung HS, Park KH, Cho YM, et al. (2006) Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 69, 76-85.
50. Lord GM, Matarese G, Howard JK, et al. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901.
51. Fernandez-Riejos P, Najib S, Santos-Alvarez J, et al. (2010) Role of leptin in the activation of immune cells. Mediators Inflamm 2010, 568343.
52. Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85, 9-18, quiz 18, 21.
53. Cho SY, Park SJ, Kwon MJ, et al. (2003) Quercetin suppresses proinflammatory cytokines production though MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243, 153-160.
54. Olsson ME, Ekvall J, Gustavsson KE, et al. (2004) Antioxidants, low molecular weight carbohydrates, and total antioxidant capacity in strawberries (Fragaria £ Ananassa): effects of cultivar, ripening, and storage. J Agric Food Chem 52, 2490-2498.
55. Zhang Y, Seeram NP, Lee R, et al. (2008) Isolation and identification of strawberry phenolics with antioxidant and human cancer cell antiproliferative properties. J Agric Food Chem 56, 670-675.
56. Hernanz D, Recamales AF, Melendez-Martinez AJ, et al. (2007) Assessment of the differences in the phenolic composition of five strawberry cultivars (Fragaria £ Ananassa Duch.) grown in two different soilless systems. J Agric Food Chem 55, 1846-1852.
57. Chen CC, Chow MP, Huang WC, et al. (2004) Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells though activator protein-1 and nuclear factor-kappaB: structure-activity relationships. Mol Pharmacol 66, 683-693.
58. Collins S, Martin TL, Surwit RS, et al. (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81, 243-248.
59. Bullen JW Jr, Bluher S, Kelesidis T, et al. (2007) Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292, E1079-E1086.
60. Seeram NP, Adams LS, Zhang Y, et al. (2006) Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem 54, 9329-9339.
61. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
62. Contrera JF, Matthews EJ, Kruhlak NL, et al. (2004) Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharmacol 40, 185-206.
63. Reagan-Shaw S, Nihal M & Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22, 659-661.
64. Ayala JE, Samuel VT, Morton GJ, et al. (2010) Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Mod Mech 3, 525-534.
65. Chan CB, Liu X, Jung DY, et al. (2010) Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance. Diabetes 59, 883-893.
66. Ranieri SC, Fusco S, Panieri E, et al. (2010) Mammalian lifespan determinant p66shcA mediates obesity-induced insulin resistance. Proc Natl Acad Sci U S A 107, 13420-13425.
67. Stephensen CB, Rasooly R, Jiang X, et al. (2002) Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J Immunol 168, 4495-4503.
68. Prior RL, Hoang H, Gu L, et al. (2003) Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absor-bance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 51, 3273-3279.
69. Basu A, Wilkinson M, Penugonda K, et al. (2009) Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J 8, 43.
70. Sesso HD, Gaziano JM, Jenkins DJ, et al. (2007) Strawberry intake, lipids, C-reactive protein, and the risk of cardiovascular disease in women. J Am Coll Nutr 26, 303-310.
71. Edirisinghe I, Banaszewski K, Cappozzo J, et al. (2011) Strawberry anthocyanin and its association with postprandial inflammation and insulin. Br J Nutr 106, 913-922.
72. Chun OK, Chung S-J, Claycombe KJ, et al. (2008) Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr 138, 753-760.
73. Torronen R, Sarkkinen E, Tapola N, et al. (2010) Berries modify the postprandial plasma glucose response to sucrose in healthy subjects. Br J Nutr 103, 1094-1097.
74. Jenkins DJ, Nguyen TH, Kendall CW, et al. (2008) The effect of strawberries in a cholesterol-lowering dietary portfolio. Metabolism 57, 1636-1644.
75. Scheyer SA, Wilson DL & LeBoeuf RC (1998) C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136, 17-24.
76. Prior RL, Wu X, Gu L, et al. (2008) Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 56, 647-653.
77. Sumiyoshi M, Sakanaka M & Kimura Y (2006) Chonic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 136, 582-587.
78. Lijnen H (2005) Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thomb Haemost 93, 816-819.
79. Klover PJ, Clementi AH & Mooney RA (2005) Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146, 3417-3427.
80. Wu H, Gower RM, Wang H, et al. (2009) Functional role of CD11c θ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119, 2708-2717.
81. Foster-Powell K, Holt SHA & Brand-Miller JC (2002) International table of glycemic index and glycemic load values:2002. Am J Clin Nutr 76, 5-56.
82. Jenkins DJA, Srichaikul K, Kendall CWC, et al. (2011) The relation of low glycaemic index fruit consumption to glycae-mic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia 54, 271-270.
83. Seymour EM, Singer AAM, Kirakosyan A, et al. (2008) Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in rats with intake of tart cherry. J Med Food 11, 252-259.
84. Takikawa M, Inoue S, Horio F, et al. (2010) Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 140, 527-533.